Amegix

Amegix

Fauci 'concerned' about slow transition between Trump and Biden

Anthony FauciAnthony FauciWhitmer responds to Atlas: I won’t ‘be bullied into not following reputable scientists’ US sees 1M new coronavirus cases in one week Cuomo threatens to sue Trump administration over vaccine distribution plan MORE, the nation’s top infectious diseases expert, on Monday said he’s “concerned” about the stalled transition process between President TrumpDonald John TrumpWhitmer responds to Atlas: I won’t ‘be bullied into not following reputable scientists’ Obama: US ‘adversaries have seen us weakened’ Obama describes wife Michelle’s resistance to presidential ambitions MORE and President-elect Biden.

“Obviously it’s something that we’re concerned about,” he said in an appearance on NBC’s “Today Show,” pointing to the need for a “smooth” process toward approving and distributing a COVID-19 vaccine.

“We want a smooth process for that,” he said. “And the way you do that is by essentially having the two groups speak to each other and exchange information.”

ADVERTISEMENT

Trump, who has not conceded the presidential election, is not providing Biden’s team access to government resources. Biden is not yet receiving intelligence briefs or interacting with other government agencies.

“As you know, I’ve served in six administrations so I’ve seen a number of transitions and I know that transitions are very important to get a smooth — I use the metaphor of passing a baton while running. Hopefully, we’ll see that soon. Transitions are important,” Fauci said.

“The virus is not going to stop and call a time-out while things change. The process is just going to keep going,” he added.

ADVERTISEMENT

The U.S. just reported more than a million new COVID-19 cases in less than a week. However, Fauci said he’s optimistic about progress toward a vaccine.

He noted that Monday’s report that Moderna’s vaccine is 95 percent effective in the latest round of testing is “a really strong step forward.”

“The vaccines are effective,” he said, also pointing to Pfizer’s recent report of a 90 percent effective vaccine attempt. “We want to get it approved as quickly as we possibly can. We want to get doses to people starting in December. And then we want to really get the ball rolling as we get into January, February, March.”

He predicted by the end of December “there will be doses of vaccines available for individuals in the higher-risk category.”

Click Here: Golf special